AstraZeneca Expands in India and China

AstraZeneca says it has opened a new $15-million process and development laboratory next to its existing R&D center at Bangalore, India. The company also announced that is has chosen Shanghai’s Zhangjiang Hi-Tech park to locate its previously announced $60-million Innovation Center China (ICC), which will serve as a temporary base for the company until it decides on a permanent location. The lab is AstraZeneca’s fourth such facility and the only one outside Europe. The facility will focus on new chemical entities (NCEs), and will soon start...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers